# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-19-026703
Filing Date
2019-12-20
Accepted
2019-12-20 16:33:04
Documents
3
Period of Report
2020-02-10
Effectiveness Date
2019-12-20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | def14a1219_citiuspharma.htm | DEF 14A | 561660
2 | GRAPHIC | image_001.jpg | GRAPHIC | 773271
3 | GRAPHIC | image_002.jpg | GRAPHIC | 335188
| Complete submission text file | 0001213900-19-026703.txt |  | 2089485

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38174 | Film No.: 191302028
SIC: 2834 Pharmaceutical Preparations